PetMed Express (PETS) 10-Q 3 Aug 20 2021 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Jun. 30, 2020	Aug. 03, 2020
Document Information [Line Items]
Entity Central Index Key	0001040130
Entity Registrant Name	PETMED EXPRESS INC
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	000-28827
Entity Incorporation, State or Country Code	FL
Entity Tax Identification Number	65-0680967
Entity Address, Address Line One	420 South Congress Avenue
Entity Address, City or Town	Delray Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33445
City Area Code	561
Local Phone Number	526-4444
Title of 12(b) Security	Common Stock, par value $.001 per share
Trading Symbol	PETS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		20,272,072

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Current assets:
Cash and cash equivalents	$ 86,821	$ 103,762
Accounts receivable, less allowance for doubtful accounts of $41 and $59, respectively	2,710	3,843
Inventories - finished goods	43,071	17,884
Prepaid expenses and other current assets	3,277	3,529
Total current assets	135,879	129,018
Noncurrent assets:
Property and equipment, net	26,016	25,445
Intangible assets	860	860
Total noncurrent assets	26,876	26,305
Total assets	162,755	155,323
Current liabilities:
Accounts payable	20,975	19,658
Accrued expenses and other current liabilities	5,169	4,214
Income taxes payable	3,025	471
Total current liabilities	29,169	24,343
Deferred tax liabilities	715	970
Total liabilities	29,884	25,313
Shareholders' equity:
Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share	9	9
Common stock, $.001 par value, 40,000 shares authorized; 20,166 and 20,166 shares issued and outstanding, respectively	20	20
Additional paid-in capital	4,544	3,804
Retained earnings	128,298	126,177
Total shareholders' equity	132,871	130,010
Total liabilities and shareholders' equity	$ 162,755	$ 155,323

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Allowance for doubtful accounts	$ 41	$ 59
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000	5,000
Preferred stock, liquidation preference (in dollars per share)	$ 4	$ 4
Preferred stock, shares issued (in shares)	3	3
Preferred stock, shares outstanding (in shares)	3	3
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	40,000	40,000
Common stock, shares issued (in shares)	20,166	20,166
Common stock, shares outstanding (in shares)	20,166	20,166

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Sales	$ 96,204	$ 79,988
Cost of sales	69,419	58,127
Gross profit	26,785	21,861
Operating expenses:
General and administrative	7,754	6,508
Advertising	9,033	8,624
Depreciation	562	568
Total operating expenses	17,349	15,700
Income from operations	9,436	6,161
Other income:
Interest income, net	90	567
Other, net	255	257
Total other income	345	824
Income before provision for income taxes	9,781	6,985
Provision for income taxes	2,013	1,642
Net income	$ 7,768	$ 5,343
Net income per common share:
Basic (in dollars per share)	$ 0.39	$ 0.26
Diluted (in dollars per share)	$ 0.39	$ 0.26
Weighted average number of common shares outstanding:
Basic (in shares)	19,984	20,235
Diluted (in shares)	20,042	20,245
Cash dividends declared per common share (in dollars per share)	$ 0.28	$ 0.27

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income	$ 7,768	$ 5,343
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	562	568
Share based compensation	740	635
Deferred income taxes	(255)	(182)
Bad debt expense	33	25
(Increase) decrease in operating assets and increase (decrease) in liabilities:
Accounts receivable	1,100	372
Inventories - finished goods	(25,187)	(8,798)
Prepaid income taxes	0	582
Prepaid expenses and other current assets	(737)	(98)
Accounts payable	1,317	(586)
Accrued expenses and other current liabilities	903	934
Income taxes payable	2,554	1,241
Net cash (used in) provided by operating activities	(11,202)	36
Cash flows from investing activities:
Purchases of property and equipment	(145)	(192)
Net cash used in investing activities	(145)	(192)
Cash flows from financing activities:
Repurchase and retirement of common stock	0	(11,496)
Dividends paid	(5,594)	(5,479)
Net cash used in financing activities	(5,594)	(16,975)
Net decrease in cash and cash equivalents	(16,941)	(17,131)
Cash and cash equivalents, at beginning of period	103,762	100,529
Cash and cash equivalents, at end of period	86,821	83,398
Supplemental disclosure of cash flow information:
Dividends payable in accrued expenses	$ 297	$ 243

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Note 1: Organization PetMed Express, Inc. and subsidiaries, d/b/a 1 800 “1 800 March 31, 2021 2020 March 31, 2021 2020, Basis of Presentation and Consolidation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10 not June 30, 2020, three June 30, 2020 2019, three June 30, 2020 2019. three June 30, 2020 not March 31, 2021. 10 March 31, 2020. Use of Estimates The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments. Recent Accounting Pronouncements In June 2016, 2016 13, 326 2016 13” 2021. 2016 13 not In December 2019, No. 2019 12, 740 2019 12” 2019 12. 2019 12 April 1, 2021. The Company does not not

Note 2 - Revenue Recognition

Note 2 - Revenue Recognition	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 2: The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company’s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one not not no The Company disaggregates revenue in the following two 1 2 Three Months Ended June 30, Revenue (In thousands) 2020 % 2019 % $ Variance % Variance Reorder Sales $ 80,425 83.6 % $ 67,742 84.7 % $ 12,683 18.7 % New Order Sales 15,779 16.4 % 12,246 15.3 % 3,533 28.9 % Total Net Sales $ 96,204 100.0 % $ 79,988 100.0 % $ 16,216 20.3 % Internet Sales $ 81,511 84.7 % $ 67,023 83.8 % $ 14,488 21.6 % Contact Center Sales 14,693 15.3 % 12,965 16.2 % 1,728 13.3 % Total Net Sales $ 96,204 100.0 % $ 79,988 100.0 % $ 16,216 20.3 % The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two three no June 30, 2020 March 31, 2020.

Note 3 - Net Income Per Share

Note 3 - Net Income Per Share	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 3 : Net Income Per Share In accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 260 Earnings Per Share The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts): Three Months Ended June 30, 2020 2019 Net income (numerator): Net income $ 7,768 $ 5,343 Shares (denominator): Weighted average number of common shares outstanding used in basic computation 19,984 20,235 Common shares issuable upon vesting of restricted stock 48 - Common shares issuable upon conversion of preferred shares 10 10 Shares used in diluted computation 20,042 20,245 Net income per common share: Basic $ 0.39 $ 0.26 Diluted $ 0.39 $ 0.26 For the three June 30, 2020 2019,

Note 4 - Accounting for Stock-b

Note 4 - Accounting for Stock-based Compensation	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	Note 4 : Accounting for Stock-Based Compensation The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 “Share Based Payment ” 2016 09 2006 “2006 2016 “2016 2006 2006 “2006 2015 “2015 2006 June 30, 2020, third one three The Company did not June 30, 2020 2019, June 30, 2020 2019, one three June 30, 2020 2019,

Note 5 - Fair Value

Note 5 - Fair Value	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 5 : Fair Value The Company carries cash and cash equivalents at fair value in the Condensed Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 three Level 1 Level 2 Level 3 no The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At June 30, 2020, 1.

Note 6 - Commitments and Contin

Note 6 - Commitments and Contingencies	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 6 : Commitments and Contingencies The Company has settled complaints that had been filed with various states’ pharmacy boards in the past. There can be no not no

Note 7 - Changes in Shareholder

Note 7 - Changes in Shareholders' Equity	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 7 : Changes in S hare holders’ Equity: Changes in shareholders’ equity for the three June 30, 2020 Additional Paid-In Retained Capital Earnings Beginning balance at March 31, 2020: $ 3,804 $ 126,177 Share based compensation 740 - Dividends declared - (5,647 ) Net income - 7,768 Ending balance at June 30, 2020: $ 4,544 $ 128,298 Changes in shareholders’ equity for the three June 30, 2019 Additional Paid-In Retained Capital Earnings Beginning balance at March 31, 2019: $ 12,478 $ 122,172 Share based compensation 635 - Dividends declared - (5,518 ) Repurchase and retirement of common stock (11,496 ) - Net income - 5,343 Ending balance at June 30, 2019: $ 1,617 $ 121,997 During the quarter ended June 30, 2019, June 30, 2020. June 30, 2020,

Note 8 - Income Taxes

Note 8 - Income Taxes	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 8 : Income Taxes For the quarters ended June 30, 2020 2019, June 30, 2020 June 30, 2020 June 30, 2019. June 30, 2020 one

Note 9 - Subsequent Events

Note 9 - Subsequent Events	3 Months Ended
	Jun. 30, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	Note 9 : Su b sequent Event s On July 20, 2020, July 31, 2020 August 7, 2020 July 31, 2020 Effective July 31, 2020, No. 8 No. 8” July 31, 2020 July 31, 2021, July 31, 2021. 2020 1 2 3 4 one No. 8, 2021 2021 1 35% 2 35% 3 20% 4 10% On July 31, 2020, 2016 2015

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Basis Of Presentation and Consolidation [Policy Text Block]	Basis of Presentation and Consolidation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10 not June 30, 2020, three June 30, 2020 2019, three June 30, 2020 2019. three June 30, 2020 not March 31, 2021. 10 March 31, 2020.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In June 2016, 2016 13, 326 2016 13” 2021. 2016 13 not In December 2019, No. 2019 12, 740 2019 12” 2019 12. 2019 12 April 1, 2021. The Company does not not

Note 2 - Revenue Recognition (T

Note 2 - Revenue Recognition (Tables)	3 Months Ended
	Jun. 30, 2020
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended June 30, Revenue (In thousands) 2020 % 2019 % $ Variance % Variance Reorder Sales $ 80,425 83.6 % $ 67,742 84.7 % $ 12,683 18.7 % New Order Sales 15,779 16.4 % 12,246 15.3 % 3,533 28.9 % Total Net Sales $ 96,204 100.0 % $ 79,988 100.0 % $ 16,216 20.3 % Internet Sales $ 81,511 84.7 % $ 67,023 83.8 % $ 14,488 21.6 % Contact Center Sales 14,693 15.3 % 12,965 16.2 % 1,728 13.3 % Total Net Sales $ 96,204 100.0 % $ 79,988 100.0 % $ 16,216 20.3 %

Note 3 - Net Income Per Share (

Note 3 - Net Income Per Share (Tables)	3 Months Ended
	Jun. 30, 2020
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, 2020 2019 Net income (numerator): Net income $ 7,768 $ 5,343 Shares (denominator): Weighted average number of common shares outstanding used in basic computation 19,984 20,235 Common shares issuable upon vesting of restricted stock 48 - Common shares issuable upon conversion of preferred shares 10 10 Shares used in diluted computation 20,042 20,245 Net income per common share: Basic $ 0.39 $ 0.26 Diluted $ 0.39 $ 0.26

Note 7 - Changes in Sharehold_2

Note 7 - Changes in Shareholders' Equity (Tables)	3 Months Ended
	Jun. 30, 2020
Notes Tables
Schedule of Stockholders Equity [Table Text Block]	Additional Paid-In Retained Capital Earnings Beginning balance at March 31, 2020: $ 3,804 $ 126,177 Share based compensation 740 - Dividends declared - (5,647 ) Net income - 7,768 Ending balance at June 30, 2020: $ 4,544 $ 128,298 Additional Paid-In Retained Capital Earnings Beginning balance at March 31, 2019: $ 12,478 $ 122,172 Share based compensation 635 - Dividends declared - (5,518 ) Repurchase and retirement of common stock (11,496 ) - Net income - 5,343 Ending balance at June 30, 2019: $ 1,617 $ 121,997

Note 2 - Revenue Recognition (D

Note 2 - Revenue Recognition (Details Textual)	3 Months Ended
	Jun. 30, 2020
Minimum [Member]
Credit Card Sales, Cash Settlement Period (Day)	2 days
Maximum [Member]
Credit Card Sales, Cash Settlement Period (Day)	3 days

Note 2 - Revenue Recognition -

Note 2 - Revenue Recognition - Disaggregation of Revenue by Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Revenues	$ 96,204	$ 79,988
Revenues, percentage	100.00%	100.00%
Revenues, variance	$ 16,216
Revenues, variance, percentage	20.30%
Internet [Member]
Revenues	$ 81,511	$ 67,023
Revenues, percentage	84.70%	83.80%
Revenues, variance	$ 14,488
Revenues, variance, percentage	21.60%
Contact Center [Member]
Revenues	$ 14,693	$ 12,965
Revenues, percentage	15.30%	16.20%
Revenues, variance	$ 1,728
Revenues, variance, percentage	13.30%
Reorder Customer [Member]
Revenues	$ 80,425	$ 67,742
Revenues, percentage	83.60%	84.70%
Revenues, variance	$ 12,683
Revenues, variance, percentage	18.70%
New Order Customer [Member]
Revenues	$ 15,779	$ 12,246
Revenues, percentage	16.40%	15.30%
Revenues, variance	$ 3,533
Revenues, variance, percentage	28.90%

Note 3 - Net Income Per Share_2

Note 3 - Net Income Per Share (Details Textual) - shares	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	72,120	136,601

Note 3 - Net Income Per Share -

Note 3 - Net Income Per Share - Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Net income (numerator):
Net income	$ 7,768	$ 5,343
Shares (denominator):
Weighted average number of common shares outstanding used in basic computation (in shares)	19,984	20,235
Common shares issuable upon vesting of restricted stock (in shares)	48	0
Common shares issuable upon conversion of preferred shares (in shares)	10	10
Shares used in diluted computation (in shares)	20,042	20,245
Net income per common share
Basic (in dollars per share)	$ 0.39	$ 0.26
Diluted (in dollars per share)	$ 0.39	$ 0.26

Note 4 - Accounting for Stock_2

Note 4 - Accounting for Stock-based Compensation (Details Textual) - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	0
2006 Employee Equity Compensation Restricted Stock Plan (the "Employee Plan") [Member] | Restricted Stock [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)	972,175
2016 Employee Equity Compensation Restricted Stock Plan [Member] | Restricted Stock [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)	153,608
2006 Outside Director Equity Compensation Restricted Stock Plan (the "Director Plan") [Member] | Restricted Stock [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)	272,000
2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan") [Member] | Restricted Stock [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)	135,000
Employee and Director Plans [Member]
Share-based Payment Arrangement, Expense	$ 740,000	$ 635,000
Employee and Director Plans [Member] | Restricted Stock [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 1,900,000	$ 3,200,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)	183,000	150,000
Employee and Director Plans [Member] | Restricted Stock [Member] | Minimum [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	1 year
Employee and Director Plans [Member] | Restricted Stock [Member] | Maximum [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	3 years

Note 5 - Fair Value (Details Te

Note 5 - Fair Value (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 86,821	$ 103,762

Note 7 - Changes in Sharehold_3

Note 7 - Changes in Shareholders' Equity (Details Textual) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Stock Repurchased and Retired During Period, Shares (in shares)	0	613,000
Stock Repurchased and Retired During Period, Value		$ 11.5
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 28.7

Note 7 - Changes in Sharehold_4

Note 7 - Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Balance	$ 130,010
Net income	7,768	$ 5,343
Repurchase and retirement of common stock		(11,500)
Balance	132,871
Additional Paid-in Capital [Member]
Balance	3,804	12,478
Share based compensation	740	635
Dividends declared	0	0
Net income	0	0
Repurchase and retirement of common stock		(11,496)
Balance	4,544	1,617
Retained Earnings [Member]
Balance	126,177	122,172
Share based compensation	0	0
Dividends declared	(5,647)	(5,518)
Net income	7,768	5,343
Repurchase and retirement of common stock		0
Balance	$ 128,298	$ 121,997

Note 8 - Income Taxes (Details

Note 8 - Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Income Tax Expense (Benefit), Total	$ 2,013,000	$ 1,642,000
Effective Income Tax Rate Reconciliation, Percent, Total	20.60%	23.50%
Proceeds from Income Tax Refunds	$ 285,000

Note 9 - Subsequent Events (Det

Note 9 - Subsequent Events (Details Textual) - USD ($)	Jul. 31, 2020	Jul. 30, 2020	Jul. 20, 2020	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)				0
Subsequent Event [Member]
Dividends Payable, Amount Per Share (in dollars per share)			$ 0.28
Dividends Payable	$ 5,600,000
Dividends Payable, Date Declared			Jul. 20, 2020
Dividends Payable, Date of Record			Jul. 31, 2020
Dividends Payable, Date to be Paid			Aug. 7, 2020
Subsequent Event [Member] | Chief Executive Officer [Member]
Annual Salary	$ 626,860	$ 607,880
Subsequent Event [Member] | Chief Executive Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	37,800
Subsequent Event [Member] | Employees [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	30,390
Subsequent Event [Member] | Director [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	37,500